Clozapine Patients Share Positive Experiences in Schizophrenia Carlat Psychiatry News

>> YOUR LINK HERE: ___ http://youtube.com/watch?v=01zjMNtfx4o

A new review in Schizophrenia Bulletin Open reveals that most patients with treatment-resistant schizophrenia prefer clozapine over other antipsychotics, citing better symptom control, mood improvement, and enhanced quality of life. While side effects like hypersalivation, weight gain, and blood monitoring are challenging, many patients find these trade-offs worthwhile due to clozapine's superior therapeutic benefits. • 💡Carlat Psychiatry: https://www.thecarlatreport.com/ • ➡️Earn CMEs: https://www.thecarlatreport.com/CMEMe... Fact • ================ • Follow Carlat: • 🔴SUBSCRIBE ► / @thecarlatreport • ➡️Twitter: / CarlatPsych • ================ • 00:00 Intro • 00:04 News Report • ================ • If you've been hesitant to prescribe clozapine for treatment-resistant schizophrenia due to concerns about side effects or blood monitoring, new data might change your perspective. A systematic review published in Schizophrenia Bulletin Open offers fresh insights into patients' experiences with clozapine, revealing a story that’s more positive than you might expect. This video breaks down the key findings from 13 studies involving over 1,400 patients who shared their personal experiences with clozapine. • The review found that the majority of patients reported significant improvements in their symptoms, mood, anxiety, and cognitive function. For many, clozapine led to better sleep and an increased ability to socialize—two critical factors for improving overall quality of life. Across multiple studies, 58–90% of patients expressed satisfaction with their clozapine experience. • Surprisingly, even when taking side effects into account, most patients still preferred clozapine over other antipsychotics they had tried. The therapeutic benefits outweighed the drawbacks, with many patients willing to tolerate issues like: • • Hypersalivation • • Weight gain • • Sedation • While some patients found the regular blood monitoring to be burdensome, many viewed it as a manageable part of treatment, especially when compared to the improvements they experienced in day-to-day functioning. For patients who have struggled for years with treatment-resistant schizophrenia, these benefits can be life-changing. • So, what does this mean for clinical practice? • These findings suggest that engaging in shared decision-making with patients about clozapine could improve acceptance of the treatment. It’s clear that while the side effects are real, patients recognize the profound impact that clozapine can have on their lives. The review underscores the importance of discussing the benefits and side effects upfront to help patients make an informed choice. For many, the promise of better symptom control, improved mood, and social engagement makes the trade-offs worthwhile. • If you're treating patients with schizophrenia who aren't responding to other medications, consider the impact that clozapine might have earlier in the treatment process. Instead of waiting for two failed antipsychotic trials, the evidence suggests that earlier use of clozapine could lead to better outcomes, especially if side effects are addressed in a supportive setting. • This video explores how clinicians can use these patient insights to have more informed, empathetic discussions about clozapine. Discover why clozapine remains the gold standard for treatment-resistant schizophrenia and how patient perspectives could shift the way you approach its use. Don't forget to like, comment, and subscribe for more updates on psychiatric treatment, schizophrenia care, and evidence-based approaches to antipsychotic use. • #clozapine #schizophrenia #mentalhealth #treatmentresistant #antipsychotics #psychopharmacology #schizophreniatreatment #medicationadherence #clozapinesideeffects #mentalhealthcare #shareddecisionmaking #schizophreniasupport #psychiatryupdates #patientexperience #psychmeds #mentalwellness

#############################

New on site